Stockreport

Metagenomi to Present at Jefferies Global Healthcare Conference in London

Metagenomi, Inc.  (MGX) 
PDF EMERYVILLE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary [Read more]